Figure 191 – Infliximab in Patients With Active Crohn’s Disease

Adapted from Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor-α for Crohn’s disease. N Engl J Med. 1997;337(15):1029-1035.